Literature DB >> 12390166

Photodynamic therapy for circumscribed choroidal haemangioma.

Irène M E Landau1, Björn Steen, Stefan Seregard.   

Abstract

PURPOSE: To assess the efficacy of photodynamic therapy (PDT) as a new treatment for circumscribed choroidal haemangioma (CCH).
METHODS: Eight patients with CCH were treated with PDT using a protocol similar to that used in the standard treatment of neovascular age-related macular degeneration.
RESULTS: Visual acuity improved in six of eight eyes, remained unchanged in one eye and deteriorated in one eye after 3-15 months (median 7 months) follow-up. Pre-treatment metamorphopsia disappeared in all but two cases. The thickness of the CCH measured with standardized echography showed marked regression within 1 month after PDT. In six eyes there was no remaining protrusion after PDT and one lesion was barely detectable. One patient experienced a transient choroidal effusion and perifoveal haemorrhage.
CONCLUSION: Photodynamic therapy is a promising new treatment for CCH as it restores visual function in most cases without causing apparent ocular or systemic side-effects.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12390166     DOI: 10.1034/j.1600-0420.2002.800513.x

Source DB:  PubMed          Journal:  Acta Ophthalmol Scand        ISSN: 1395-3907


  10 in total

Review 1.  Lasers for the treatment of intraocular tumors.

Authors:  Samuel K Houston; Charles C Wykoff; Audina M Berrocal; Ditte J Hess; Timothy G Murray
Journal:  Lasers Med Sci       Date:  2013-05       Impact factor: 3.161

Review 2.  The role of photodynamic therapy in the treatment of symptomatic choroidal hemangioma.

Authors:  Bernhard Jurklies; Norbert Bornfeld
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-02-08       Impact factor: 3.117

3.  Single spot PDT in patients with circumscribed choroidal haemangioma and near normal visual acuity.

Authors:  F D Verbraak; R O Schlingemann; M D de Smet; J E E Keunen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-02-28       Impact factor: 3.117

Review 4.  Ocular phototherapy.

Authors:  A D Singh
Journal:  Eye (Lond)       Date:  2012-12-14       Impact factor: 3.775

Review 5.  Photodynamic therapy of circumscribed choroidal haemangioma.

Authors:  A D Singh; P K Kaiser; J E Sears; M Gupta; P A Rundle; I G Rennie
Journal:  Br J Ophthalmol       Date:  2004-11       Impact factor: 4.638

6.  Longstanding symptomatic choroidal hemangioma managed with limited PDT as initial or salvage therapy.

Authors:  F D Verbraak; R O Schlingemann; J E E Keunen; M D de Smet
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-10-18       Impact factor: 3.117

Review 7.  Verteporfin PDT for non-standard indications--a review of current literature.

Authors:  Wai Man Chan; Tock-Han Lim; Alfredo Pece; Rufino Silva; Nagahisa Yoshimura
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-02-17       Impact factor: 3.117

8.  Photodynamic Therapy for Circumscribed Choroidal Haemangioma in a Scottish Cohort.

Authors:  Aaron Jamison; Paul Cauchi; David F Gilmour
Journal:  Ocul Oncol Pathol       Date:  2018-02-14

9.  Transient increased exudation after photodynamic therapy of intraocular tumors.

Authors:  Arman Mashayekhi; Carol L Shields; Jerry A Shields
Journal:  Middle East Afr J Ophthalmol       Date:  2013 Jan-Mar

10.  High recurrence rate in patients with choroidal hemangioma treated with limited single spot photodynamic therapy during long-term follow-up.

Authors:  Marilette Stehouwer; Reinier O Schlingemann; Frank D Verbraak
Journal:  Acta Ophthalmol       Date:  2020-04-14       Impact factor: 3.761

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.